Evidence map›Paper›PMID 28410367›Full record

ArticlePloS one2017

Nitric oxide charged catheters as a potential strategy for prevention of hospital acquired infections.

David Margel, Mark Mizrahi, Gili Regev-Shoshani, Mary Ko, Maya Moshe, Rachel Ozalvo, Liat Shavit-Grievink, Jack Baniel, Daniel Kedar, Ofer Yossepowitch and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Antibiofilm agents: A new perspective for antimicrobial strategy.Journal of microbiology (Seoul, Korea) · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

David MargelDivision of Urology, Rabin Medical Center and Tel-Aviv University, Sackler School of Medicine, Petach-Tikva, Israel.
Mark MizrahiENOX Ltd., Habarzel 38, Tel-Aviv, Israel.
Gili Regev-ShoshaniDepartment of Medicine, Division of Infectious Disease, University of British Columbia, British Columbia Province, Vancouver, Canada.
Mary KoDepartment of Medicine, Division of Infectious Disease, University of British Columbia, British Columbia Province, Vancouver, Canada.
Maya MosheDivision of Urology, Rabin Medical Center and Tel-Aviv University, Sackler School of Medicine, Petach-Tikva, Israel.
Rachel OzalvoDivision of Urology, Rabin Medical Center and Tel-Aviv University, Sackler School of Medicine, Petach-Tikva, Israel.
Liat Shavit-GrievinkDivision of Urology, Rabin Medical Center and Tel-Aviv University, Sackler School of Medicine, Petach-Tikva, Israel.
Jack BanielDivision of Urology, Rabin Medical Center and Tel-Aviv University, Sackler School of Medicine, Petach-Tikva, Israel.
Daniel KedarDivision of Urology, Rabin Medical Center and Tel-Aviv University, Sackler School of Medicine, Petach-Tikva, Israel.
Ofer YossepowitchDivision of Urology, Rabin Medical Center and Tel-Aviv University, Sackler School of Medicine, Petach-Tikva, Israel.
David LifshitzDivision of Urology, Rabin Medical Center and Tel-Aviv University, Sackler School of Medicine, Petach-Tikva, Israel.
Andrei NaduDivision of Urology, Rabin Medical Center and Tel-Aviv University, Sackler School of Medicine, Petach-Tikva, Israel.
David GreenbergENOX Ltd., Habarzel 38, Tel-Aviv, Israel.
Yossef Av-GayENOX Ltd., Habarzel 38, Tel-Aviv, Israel.
Tel Aviv University · ILRabin Medical Center · ILUniversity of British Columbia · CAMellanox Technologies (Israel) · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCatheter-Associated Hospital-Acquired Infections (HAI's) are caused by biofilm-forming bacteria. Using a novel approach, we generated anti-infective barrier on catheters by charging them with Nitric Oxide (NO), a naturally-produced gas molecule. NO is slowly released from the catheter upon contact with physiological fluids, and prevents bacterial colonization and biofilm formation onto catheter surfaces. AIMS AND

methodsThe aim of the study was to assess the anti-infective properties of NO-charged catheters exposed to low concentration (up to 103 CFU/ml) of microbial cells in-vitro. We assessed NO-charged tracheal tubes using Pseudomonas aeruginosa, dialysis and biliary catheters using Escherichia coli, and urinary catheters using E. coli, Candida albicans or Enterococcus faecalis. Safety and tolerability of NO-charged urinary catheters were evaluated in a phase 1 clinical study in 12 patients. Six patients were catheterized with NO-charged catheters (NO-group), followed by 6 patients catheterized with regular control catheters (CT-group). Comparison of safety parameters between the study groups was performed.

resultsNO-charged tracheal, dialysis biliary and urinary catheters prevented P. aeruginosa, E. coli and C. albicans attachment and colonization onto their surfaces and eradicated corresponding planktonic microbial cells in the surrounding media after 24-48 hours, while E. faecalis colonization onto urinary catheters was reduced by 1 log compared to controls. All patients catheterized with an NO-charged urinary catheter successfully completed the study without experiencing NO-related AE's or serious AE's (SAE's).

conclusionThese data highlight the potential of NO-based technology as potential platform for preventing catheter-associated HAI's.

Indexed as

AgedBacterial AdhesionCandida albicansCase-Control StudiesCatheter-Related InfectionsEnterococcus faecalisEscherichia coliFollow-Up StudiesHematuriaHemoglobinsHumansMaleMiddle AgedNitric OxideProspective StudiesPseudomonas aeruginosaHemoglobinsNitric Oxide

Identifiers

PMID28410367
PMCPMC5391919
OpenAlexW2953405287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.